STS uses PRT to ensure patient safety
Secure Transfusion Solutions (STS) is the only commercial blood collection enterprise that makes 100% use of pathogen-reduction technology (PRT), a system approved by the US Food and Drug Administration (FDA) that minimizes the risk of bacterial and viral contamination in platelet collections.
Use of PRT eliminates the need for irradiation and provides potential protection against emerging pathogens. Our goal at STS is to be a trusted, reliable and safe source of platelets for hospitals as they deliver life-saving care to patients.
Read the data that show that PRT reduces pathogens in blood transfusions.
EXPANDED DONOR POOL
Providing enhanced availability and reliability of apheresis platelets from a diverse, younger donor population.
Reducing supply chain interruptions to eliminate the impact to patient care